Eczema: all 1,088 studies

Page 10 of 11. Open to participants first (130), then studies with results posted, then the rest; newest registration first within each.

• KM110329 in Adult Patients With Atopic DermatitisStatus unknownNCT01692093Phase 2
• Efficacy/Safety Study to Explore a New Topical Formulation in Atopic DermatitisWithdrawnNCT01691209Not applicable
• Clinical Importance of Filaggrin Gene Mutation for Treatment Outcome in Atopic DermatitisStatus unknownNCT01689805
• Single Center Study Using Omalizumab in Subjects With Atopic DermatitisCompletedNCT01678092Phase 1
• A Study Comparing the Efficacy of Two Topical Steroid Application Regimens in Pediatric Patients With Atopic DermatitisCompletedNCT01675232Not applicable
• Eczema Action Plan Improves Patient and Caregiver Understanding and Perception of Atopic Dermatitis ManagementCompletedNCT01660217Not applicable
• Effectiveness of Melatonin for Sleep Disturbances in Children With Atopic DermatitisCompletedNCT01638234Phase 2/3
• Probiotics and Allergic DiseasesCompletedNCT01635738Not applicable
• A Two-Part, Phase 1, Single-Dose Study of IL-31 mAb (Anti-Interleukin 31 Monoclonal Antibody); in Healthy Subjects and Adults With Atopic DermatitisCompletedNCT01614756Phase 1
• Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic DermatitisTerminatedNCT01605708Phase 1/2
• Efficacy and Safety of a a Biofunctional Textile in the Management of Atopic DermatitisCompletedNCT01597817Phase 2
• Narrowband UVB for Children With Moderate to Severe Atopic EczemaCompletedNCT01569906
• Phase 2 Study of HL-009 Liposomal Gel to Treat Mild to Moderate Atopic DermatitisCompletedNCT01568489Phase 2
• Randomised, Double-blind, Placebo-controlled Study of Topical Clobetasone Butyrate 0.05% Cream in Subjects With Eczema for Two Weeks to Evaluate the Efficacy and SafetyCompletedNCT01567995Phase 3
• A Study Evaluating the Safety and Efficacy of QGE031 in Atopic Dermatitis PatientsCompletedNCT01552629Phase 2
• Atopic Dermatitis Research Network (ADRN) Influenza Vaccine PilotCompletedNCT01518478Early Phase 1
• Probiotics in Adults: do They Improve Atopic Dermatitis?CompletedNCT01500941Phase 3
• The Cork BASELINE Birth Cohort StudyStatus unknownNCT01498965
• A Study of JNJ-39758979 in Adult Japanese Patients With Moderate Atopic DermatitisTerminatedNCT01497119Phase 2
• Registry for the Atopic Dermatitis Research NetworkCompletedNCT01494142
• Chronic Hand Eczema - Self-management and PrognosisCompletedNCT01482663Not applicable
• Effect of Pollen Challenges on Dermal Symptoms in Patients With Atopic DermatitisCompletedNCT01475994Not applicable
• Treatment of IgE Associated Eczema With Omega-3 Long Chain Polyunsaturated Fatty Acids in Infancy and the Development of Bronchial Asthma in ChildhoodStatus unknownNCT01473823Not applicable
• Sublingual Immunotherapy in Patients With Atopic DermatitisCompletedNCT01471119Phase 2
• Efficacy Emollient on Xerosis in Children With Atopic DermatitisCompletedNCT01467362Phase 3
• A Phase 2 Study of E6005 in Patients With Atopic DermatitisCompletedNCT01461941Phase 2
• Safety, Tolerability and Pharmacokinetics of LEO 29102 Cream in Atopic Dermatitis.TerminatedNCT01447758Phase 1
• Interferon Responses in Eczema HerpeticumCompletedNCT01429311
• A Study Evaluating the Safety and Efficacy of Topical BPR277 for the Treatment of Atopic Dermatitis and Netherton SyndromeCompletedNCT01428297Phase 1
• HPA Axis Study in AdultsCompletedNCT01408511Phase 2
• HPA Axis Study in Japanese AdultsCompletedNCT01407510Phase 2
• Narrow-band (NB)-UVB vs. Bath-PUVA and NB-UVB Plus Salt Water Baths in Atopic DermatitisTerminatedNCT01402414Not applicable
• Safety and Tolerability of Dupilumab in Participants With Moderate to Severe Atopic DermatitisCompletedNCT01385657Phase 1
• Pediatric Atopic Dermatitis (AD) Internet SurveyWithdrawnNCT01385527Not applicable
• Efficacy and Safety of Different Concentrations of Mapracorat Ointment Over 4 Weeks in Atopic Dermatitis (AD)CompletedNCT01359787Phase 2
• Investigation of the Efficacy of 2.5% and 5% Cis-urocanic Acid in Patients With Moderate or Severe Atopic DermatitisCompletedNCT01320579Phase 2
• Chemokine Expression in Nummular Dermatitis and Atopic DermatitisStatus unknownNCT01311986
• Climatotherapy At The Dead Sea For Atopic DermatitisStatus unknownNCT01307150
• Dilute Bleach Baths in Pediatric Patients With Atopic DermatitisTerminatedNCT01286220Not applicable
• Effectiveness of Clemastine Fumarate + Dexamethasone Compared to Dexchlorpheniramine Maleate in Eczema TreatmentCompletedNCT01257061Phase 3
• Safety, Efficacy and Pharmacokinetic Study of Allegra in Pediatric Patients With Atopic Dermatitis (AD)CompletedNCT01244230Phase 2/3
• Autologous Serum Skin Testing in Patients With Atopic Dermatitis Autologous Serum Skin Testing in Patients With Atopic DermatitisCompletedNCT01238263
• Asthma, Missed Immunizations, and Vitamin D Deficiency in Atopic DermatitisTerminatedNCT01234909
• Efficacy and Tolerability Study of Device, RD047-26 for the Treatment of Mild to Moderate Atopic Dermatitis in AdultsCompletedNCT01232985Phase 2
• Safety Study Evaluating the Adrenal Suppression Potential of Product 0405 in Pediatric Subjects With Atopic DermatitisCompletedNCT01232543Phase 2
• Management of Eczema by Specific Probiotic StrainsWithdrawnNCT01230190Phase 3
• Efficacy and Safety of Different Concentrations of ZK245186 in Atopic Dermatitis (AD)CompletedNCT01228513Phase 2
• Effect of Probiotics in the Atopic DermatitisCompletedNCT01224132Phase 3
• A Study to Evaluate Safety, Tolerability and Efficacy of Lytixar™ (LTX-109) on Uncomplicated, Gram-positive, Skin InfectionCompletedNCT01223222Phase 2
• Text Messaging and Atopic DermatitisCompletedNCT01216059Not applicable
• Bilateral Comparison Study of Elidel 1% and Hylatopic Plus Emollient Foam for the Treatment of Subjects With Atopic DermatitisCompletedNCT01202149Phase 4
• A Study of E6005 in Japanese Patients With Atopic DermatitisCompletedNCT01179880Phase 1/2
• Atopic Dermatitis Biomarker Identification Trial in Omalizumab UsageCompletedNCT01179529Phase 2
• Pimecrolimus Cream 1% (Elidel®) and Medicated Device Cream (EletoneTM) in the Treatment and Maintenance of Atopic Dermatitis.CompletedNCT01177566Phase 4
• Evaluation of A-1 Cool Cream Efficacy for Treatment Atopic DermatitisStatus unknownNCT01174511Phase 1/2
• Lactobacillus Rhamnosus GG: Interaction With Human Microbiota and ImmunityCompletedNCT01148667Phase 4
• Group Eczema Education Visits:Impact on Patient and Family Quality of LifeCompletedNCT01143012Not applicable
• Feasibility Study of Barrier Enhancement for Eczema PreventionStatus unknownNCT01142999Not applicable
• Health Literacy for Children With Atopic Dermatitis and Their CaregiversTerminatedNCT01138761Not applicable
• K301 for the Treatment of Seborrhoeic Eczema (SE) of the ScalpCompletedNCT01137331Phase 3
• Pimecrolimus and Epidermal Barrier FunctionCompletedNCT01132079Not applicable
• A Pilot Study of Lactofiltrum to Treat Atopic Dermatitis in AdultsCompletedNCT01124318Phase 2/3
• A Pilot Study Using Anakinra/Kineret for the Treatment of Patients With Severe Atopic DermatitisTerminatedNCT01122914Phase 1
• Study to Investigate Skin Conditions and Patient Assessment of LAS 41002 in the Treatment of Atopic EczemaCompletedNCT01119313Phase 2
• Non-steroid, Atopic Dermatitis Phase IIb 12-week Trial; Topical WBI-1001 CreamCompletedNCT01098734Phase 2
• Efficacy and Safety of an Ectoine-containing Cream in the Treatment of Mild to Moderate Atopic DermatitisCompletedNCT01079897Not applicable
• Analysis of the Quality of Life, the Clinical Effectiveness and Cost-effectiveness of a Novel Educational Programme in Patients With Psoriasis and Atopic DermatitisCompletedNCT01077882Phase 4
• Knowledge Base in the Treatment of Atopic Dermatitis Among Thai PediatriciansCompletedNCT01069666
• the Effectiveness of Probiotics on Atopic Dermatitis With Cow Milk AllergyWithdrawnNCT01045486Not applicable
• Safety and Efficacy of DNK333 in Atopic Dermatitis PatientsCompletedNCT01033097Phase 2
• Efficacy and Safety of LAS41003 in the Treatment of Superficial Infected EczemaCompletedNCT01020994Phase 2
• A Randomised Clinical Trial in a Population of Health Care Workers With Hand EczemaStatus unknownNCT01012453Not applicable
• Probiotic Bacteria to Infants With Atopic DermatitisCompletedNCT01007331Not applicable
• A Safety, Tolerability and Pharmacokinetic Study of LEO 29102 in Subjects With Atopic DermatitisCompletedNCT01005823Phase 1
• CT 327 in the Treatment of Atopic DermatitisTerminatedNCT00996008Phase 2
• The Role of Topically Dissolved Oxygen (TDO) to Ameliorate Signs of PhotodamageCompletedNCT00991198Phase 2
• Comparison Between Asynchronous Online Care Model With Usual In Office Care for the Management of Atopic DermatitisCompletedNCT00985894Not applicable
• Dose-Finding Study of M516102 in the Treatment of Pruritus Associated With Atopic DermatitisCompletedNCT00980629Phase 2
• Sinecort Pilot Efficacy StudyCompletedNCT00980135Phase 2
• Dose Escalation of Different Concentrations of ZK 245186 in Atopic DermatitisCompletedNCT00944632Phase 2
• A Study to Determine the Safety, Tolerability and Efficacy of KP-413 in Subjects With Atopic Dermatitis(AD)CompletedNCT00932074Phase 1/2
• Topical Application of AS101 for the Treatment of Atopic DermatitisTerminatedNCT00927212Phase 2
• Open-label Study to Investigate Systemic Exposure in Adult and Pediatric Atopic Dermatitis Patients Treated 8.5 Days With Pimecrolimus Cream 1% Under OcclusionCompletedNCT00925730Phase 4
• Probiotics in Prevention of Allergies, Obesity and CariesCompletedNCT00894816Not applicable
• A Study of a Probiotic in Atopic DermatitisCompletedNCT00893230Phase 3
• A Study of BRT-FC-83C for the Treatment of Atopic DermatitisCompletedNCT00883311Phase 2
• Safety and Efficacy of SRD441 Ointment in Patients With Atopic DermatitisCompletedNCT00882245Phase 2
• Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass IndexCompletedNCT00879944
• Vitamin D Supplementation in Childhood Atopic DermatitisCompletedNCT00879424Not applicable
• Investigation of Efficacy and Safety of EPOGAMCompletedNCT00878670Phase 4
• Trial of Treatment of Atopic Dermatitis With Concurrent Altabax® and Topical Low-Potency Corticosteroids Versus Low-Potency Corticosteroid Mono-therapyWithdrawnNCT00871208Phase 4
• Vitamin D Supplementation During Pregnancy for Prevention of Asthma in ChildhoodActive, not recruitingNCT00856947Phase 1
• Phase IIa Safety and Efficacy Study of SRD174 Cream in Patients With AD-associated PruritusCompletedNCT00838708Phase 2
• Bioequivalence of Two Tacrolimus 0.1% Topical Ointment Formulations in Patients With Atopic DermatitisCompletedNCT00833079Phase 1
• Comparison of Video-Based Versus Written Patient Education on Atopic DermatitisCompletedNCT00826592Not applicable
• Study to Determine the Effect of an Anti-IgE Agent on Inflammatory Cells in the Skin of Atopic Dermatitis PatientsCompletedNCT00822783Phase 4
• The Underlying Mechanisms For S. Aureus Infection And Colonization Of Skin in People With Atopic Dermatitis With And Without Eczema Herpeticum (MRSA)CompletedNCT00822276
• Fractional Exhaled Nitric Oxide (FeNO) Result Prediction Factors in Children With Allergic DiseasesCompletedNCT00815984
• Study of Pimecrolimus Treatment for Atopic Dermatitis of African American ChildrenTerminatedNCT00810862Phase 4
• Equivalence of the Response to Vaccination of Tacrolimus Ointment to a Steroid Ointment Regimen in Children With Atopic DermatitisCompletedNCT00801957Phase 2

← Eczema overview